160 related articles for article (PubMed ID: 23246489)
1. PRR11 is a novel gene implicated in cell cycle progression and lung cancer.
Ji Y; Xie M; Lan H; Zhang Y; Long Y; Weng H; Li D; Cai W; Zhu H; Niu Y; Yang Z; Zhang C; Song F; Bu Y
Int J Biochem Cell Biol; 2013 Mar; 45(3):645-56. PubMed ID: 23246489
[TBL] [Abstract][Full Text] [Related]
2. RNAi-mediated silencing of praline-rich gene causes growth reduction in human lung cancer cells.
Zhao Q
Int J Clin Exp Pathol; 2015; 8(2):1760-7. PubMed ID: 25973065
[TBL] [Abstract][Full Text] [Related]
3. PRR11 regulates late-S to G2/M phase progression and induces premature chromatin condensation (PCC).
Zhang C; Zhang Y; Li Y; Zhu H; Wang Y; Cai W; Zhu J; Ozaki T; Bu Y
Biochem Biophys Res Commun; 2015 Mar; 458(3):501-508. PubMed ID: 25666944
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.
Huang Y; Ni R; Wang J; Liu Y
Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440
[TBL] [Abstract][Full Text] [Related]
5. HEDGEHOG/GLI Modulates the PRR11-SKA2 Bidirectional Transcription Unit in Lung Squamous Cell Carcinomas.
Sun Y; Xu D; Zhang C; Wang Y; Zhang L; Qiao D; Bu Y; Zhang Y
Genes (Basel); 2021 Jan; 12(1):. PubMed ID: 33477943
[TBL] [Abstract][Full Text] [Related]
6. The PRR11-SKA2 Bidirectional Transcription Unit Is Negatively Regulated by p53 through NF-Y in Lung Cancer Cells.
Wang Y; Weng H; Zhang Y; Long Y; Li Y; Niu Y; Song F; Bu Y
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28257042
[TBL] [Abstract][Full Text] [Related]
7. Proline-rich protein 11 silencing inhibits hepatocellular carcinoma growth and epithelial-mesenchymal transition through β-catenin signaling.
Qiao W; Wang H; Zhang X; Luo K
Gene; 2019 Jan; 681():7-14. PubMed ID: 30248355
[TBL] [Abstract][Full Text] [Related]
8. The gene pair PRR11 and SKA2 shares a NF-Y-regulated bidirectional promoter and contributes to lung cancer development.
Wang Y; Zhang Y; Zhang C; Weng H; Li Y; Cai W; Xie M; Long Y; Ai Q; Liu Z; Du G; Wang S; Niu Y; Song F; Ozaki T; Bu Y
Biochim Biophys Acta; 2015 Sep; 1849(9):1133-44. PubMed ID: 26162986
[TBL] [Abstract][Full Text] [Related]
9. PRR11 and SKA2 gene pair is overexpressed and regulated by p53 in breast cancer.
Wang Y; Zhang C; Mai L; Niu Y; Wang Y; Bu Y
BMB Rep; 2019 Feb; 52(2):157-162. PubMed ID: 30760381
[TBL] [Abstract][Full Text] [Related]
10. miR-195 inhibits cell proliferation and angiogenesis in human prostate cancer by downregulating PRR11 expression.
Cai C; He H; Duan X; Wu W; Mai Z; Zhang T; Fan J; Deng T; Zhong W; Liu Y; Zhong W; Zeng G
Oncol Rep; 2018 Apr; 39(4):1658-1670. PubMed ID: 29393495
[TBL] [Abstract][Full Text] [Related]
11. miR-144-3p Induces Cell Cycle Arrest and Apoptosis in Pancreatic Cancer Cells by Targeting Proline-Rich Protein 11 Expression via the Mitogen-Activated Protein Kinase Signaling Pathway.
Li J; Sun P; Yue Z; Zhang D; You K; Wang J
DNA Cell Biol; 2017 Aug; 36(8):619-626. PubMed ID: 28574724
[TBL] [Abstract][Full Text] [Related]
12. TMEM45B, up-regulated in human lung cancer, enhances tumorigenicity of lung cancer cells.
Hu R; Hu F; Xie X; Wang L; Li G; Qiao T; Wang M; Xiao H
Tumour Biol; 2016 Sep; 37(9):12181-12191. PubMed ID: 27225290
[TBL] [Abstract][Full Text] [Related]
13. PRR11 Is a Prognostic Marker and Potential Oncogene in Patients with Gastric Cancer.
Song Z; Liu W; Xiao Y; Zhang M; Luo Y; Yuan W; Xu Y; Yu G; Hu Y
PLoS One; 2015; 10(8):e0128943. PubMed ID: 26252227
[TBL] [Abstract][Full Text] [Related]
14. Proline-rich 11 (PRR11) promotes the progression of cutaneous squamous cell carcinoma by activating the EGFR signaling pathway.
Wang S; Zhang X; Lei H; Song L; Huang Y; Kang T; Zhang M; Wang N; Yang P; Feng S; Wang J; Bai R; Wang N; Wang W; Zheng Y
Mol Carcinog; 2023 May; 62(5):613-627. PubMed ID: 36727626
[TBL] [Abstract][Full Text] [Related]
15. PRR11 immunoreactivity is a weak prognostic factor in non-mucinous invasive adenocarcinoma of the lung.
Sakai Y; Ohbayashi C; Yanagita E; Jimbo N; Kajimoto K; Sakuma T; Hirose T; Yoshimura M; Maniwa Y; Itoh T
Pathologica; 2017 Sep; 109(3):133-139. PubMed ID: 29154370
[TBL] [Abstract][Full Text] [Related]
16. PRR11 Overexpression Facilitates Ovarian Carcinoma Cell Proliferation, Migration, and Invasion Through Activation of the PI3K/AKT/β-Catenin Pathway.
Zhu J; Hu H; Wang J; Yang Y; Yi P
Cell Physiol Biochem; 2018; 49(2):696-705. PubMed ID: 30165366
[TBL] [Abstract][Full Text] [Related]
17. PRR11 in Malignancies: Biological Activities and Targeted Therapies.
Han W; Chen L
Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551227
[TBL] [Abstract][Full Text] [Related]
18. Silencing of PRR11 suppresses cell proliferation and induces autophagy in NSCLC cells.
Zhang L; Lei Y; Zhang Y; Li Y; Bu Y; Song F; Zhang C
Genes Dis; 2018 Jun; 5(2):158-166. PubMed ID: 30258945
[TBL] [Abstract][Full Text] [Related]
19. Role of Prognostic Marker
Wang WH; Ma CG; Cui YS; Bai BY; Sheng ZM; Liu J; Li A; Zhang BG
Biomed Environ Sci; 2023 Sep; 36(9):862-868. PubMed ID: 37803898
[TBL] [Abstract][Full Text] [Related]
20. B-Myb Mediates Proliferation and Migration of Non-Small-Cell Lung Cancer via Suppressing IGFBP3.
Fan X; Wang Y; Jiang T; Cai W; Jin Y; Niu Y; Zhu H; Bu Y
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
